As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Multiple approaches for SARS-CoV-2 sequencing
Yanyan Zhang, Weijun Chen, Yimin Li, Junhua Li and colleagues present a comparative analysis of sequencing approaches for SARS-CoV-2.
Epigenetic mitotic-like clocks for cancer
Andrew Teschendorff presents a newly developed epigenetic mitotic clock model, epiTOC2, for cancer risk prediction.
Fecal microbiota transplantation
Nicolas Benech and Harry Sokol discuss recent treatment advances of fecal microbiota transplantation.
Review on polygenic risk scores
Cathryn Lewis and Evangelos Vassos discuss recent advances in the field of polygenic risk scores.
Reviews, Research Highlights and Commentaries
Read authoritative Reviews, Opinions and other content commissioned by the Genome Medicine Editors from leading researchers:
Commentaries (including Editorials, Comments, Opinions, Q&As and Meeting reports)
Articles
-
-
Illuminating the human virome in health and disease
-
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
-
A single early-in-life antibiotic course increases susceptibility to DSS-induced colitis
-
Cytokine-induced molecular responses in airway smooth muscle cells inform genome-wide association studies of asthma
-
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
-
A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications
-
Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials
-
The virome: a missing component of biological interaction networks in health and disease
-
Impact of the gut microbiota on inflammation, obesity, and metabolic disease
Focus: Approaches to Data Analysis
Read the latest papers on the approaches to data analysis across BMC flagship journals.
The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence
Peng Xue et al.
Published in BMC Medicine 03 June 2020
ImageJ SurfCut: a user-friendly pipeline for high-throughput extraction of cell contours from 3D image stacks
Özer Erguvan et al.
Published in BMC Biology 09 May 2019
An unsupervised learning approach to identify novel signatures of health and disease from multimodal data
Ilan Shomorony et al.
Published in Genome Medicine 10 January 2020
DISC: a highly scalable and accurate inference of gene expression and structure for single-cell transcriptomes using semi-supervised deep learning
Yao He et al.
Published in Genome Biology 10 July 2020
Aims and scope
Genome Medicine publishes important advances of broad interest in the application of genetics, genomics and multi-omics to understand, diagnose and treat disease. The Journal aims to bridge the basic science and clinical research communities in areas that include, but are not limited to: cancer genomics, immuno-oncology, immunogenomics, infectious disease, microbiome, neurogenomics, systems medicine, clinical genomics, gene therapies, precision medicine, and clinical trials. The Journal content includes original research, method, software, database and guideline articles as well as reviews, opinions and commentaries.
Article collections
Special issue
Clinical interpretation of genome variation
Guest editors: Heidi Rehm and Douglas Fowler
Collection
A decade of Genome Medicine
Special issue
Tumor immune microenvironment and immunotherapy
Guest editors: Zlatko Trajanoski and Noel de Miranda
Special issue
From genome integrity to cancer
Guest editor: Serena Nik-Zainal
From the blog
-
-
ISRCTN 20th Anniversary Quiz
16 July 2020
-
Making clinical trials public for 20 years
15 July 2020
- Editorial Board
- Editorial Team
- Sign up for article alerts and news from this journal
- Contact us
-
Announcements
Portable peer review
To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.
COVID-19 submissions
In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.
Follow
2019 Journal Metrics
-
Citation Impact
10.675 - 2-year Impact Factor
10.637 - 5-year Impact Factor
1.833 - Source Normalized Impact per Paper (SNIP)
5.084 - SCImago Journal Rank (SJR)
